化疗加贝瓦西祖马布治疗转移性结直肠癌的化疗免疫疗法:现实世界的分析
Zhao Gao1, Zheng-Fei Zhou2, Xiao-Yan Wang3
1Department of Medical Oncology, Peking University First Hospital, Beijing 100034, China.
World journal of gastrointestinal oncology
|September 22, 2025
概括
与标准化疗相比,一线化疗免疫疗法 (CIT) 在微卫星稳定 (MSS) 转移性结直肠癌 (mCRC) 中改善了无进展生存率. 这表明CIT可能是MSS mCRC患者更有效的治疗选择.
科学领域:
- 在瘤学瘤学.
- 临床药理学 临床药理学
背景情况:
- 化疗可以增强免疫治疗的疗效.
- 有证据表明,联合治疗在癌症治疗中可能发挥作用.
研究的目的:
- 评估一线化疗免疫治疗 (CIT) 与微卫星稳定 (MSS) 转移性结直肠癌 (mCRC) 患者的标准护理 (SOC) 的有效性.
主要方法:
- 多中心回顾性队列研究.
- 使用Kaplan-Meier方法和Cox比例危险模型来评估无进展生存期 (PFS).
- 倾向性得分 (PS) 分析,包括反向概率加权和PS匹配,用于平衡队列特征.
主要成果:
- 化疗免疫疗法 (CIT) 与标准护理 (SOC) 相比,显示了较长的中位数无进展生存期 (PFS).
- 在多项统计分析中,危险比率始终有利于CIT,这表明PFS的显著改善.
- 经过调整后的分析证实,CIT在MSS mCRC患者中显著改善了PFS.
结论:
- 第一线化疗免疫疗法 (CIT) 可能为微卫星稳定 (MSS) 转移性结直肠癌 (mCRC) 提供比标准化疗更高的疗效.
- 对预测生物标志物和患者子组进行进一步的研究是有必要的,以优化CIT利用.
更多相关视频
08:12Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
6.0K
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
11.5K
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Survival Analysis
650
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
650
